Horst & Graben Wealth Management’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,029
| Closed | -$37.9K | – | 160 |
|
|
2024
Q3 | $37.9K | Hold |
3,029
| – | – | 0.01% | 154 |
|
|
2024
Q2 | $44.2K | Hold |
3,029
| – | – | 0.01% | 151 |
|
|
2024
Q1 | $67.9K | Hold |
3,029
| – | – | 0.01% | 144 |
|
|
2023
Q4 | $57.3K | Hold |
3,029
| – | – | 0.01% | 136 |
|
|
2023
Q3 | $51.8K | Hold |
3,029
| – | – | 0.01% | 134 |
|
|
2023
Q2 | $91K | Hold |
3,029
| – | – | 0.02% | 130 |
|
|
2023
Q1 | $89K | Buy |
+3,029
| New | +$89K | 0.02% | 130 |
|
|
2022
Q4 | – | Sell |
-3,029
| Closed | -$92K | – | 127 |
|
|
2022
Q3 | $92K | Hold |
3,029
| – | – | 0.03% | 123 |
|
|
2022
Q2 | $70K | Hold |
3,029
| – | – | 0.02% | 131 |
|
|
2022
Q1 | $136K | Hold |
3,029
| – | – | 0.03% | 134 |
|
|
2021
Q4 | $117K | Hold |
3,029
| – | – | 0.03% | 133 |
|
|
2021
Q3 | $154K | Hold |
3,029
| – | – | 0.04% | 133 |
|
|
2021
Q2 | $264K | Buy |
3,029
+1,045
| +53% | +$91.1K | 0.07% | 108 |
|
|
2021
Q1 | $88K | Buy |
+1,984
| New | +$88K | 0.03% | 128 |
|